Astellas Pharma (ALPMY) Stock Chart & Stock Price History $10.45 -0.43 (-3.91%) As of 03:58 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesSEC FilingsShort InterestBuy This Stock Astellas Pharma Stock Price Performance The Astellas Pharma (ALPMY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 11.78%, with a year-to-date return of 8.13%. In the past month, the stock has decreased 8.14%, reflecting recent market activity. As of the latest close, Astellas Pharma traded at $10.87 with a market cap of and volume of 199,363 shares. Five years ago, the stock traded at $14.17, representing a 26.26% decrease over that period. At the time, it had a market cap of and a volume of 69,488 shares. Receive ALPMY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Astellas Pharma and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-5.22%1 Month Performance-8.14%3 Month Performance+11.00%Year-To-Date Performance+8.13%1 Year Performance-11.78%5 Year Performance-26.26% ALPMY Stock Chart for Friday, October, 10, 2025 ALPMY Chart by TradingView Astellas Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/10/2025$10.87$10.45-3.91%$11.03$10.4386,707 shs$0.0010/09/2025$10.81$10.87+0.56%$11.30$10.48199,363 shs$0.0010/08/2025$10.92$10.81-1.02%$11.21$10.7952,163 shs$0.0010/07/2025$11.09$10.92-1.53%$11.07$10.9265,489 shs$0.0010/06/2025$11.02$11.09+0.64%$11.09$11.0485,725 shs$0.0010/03/2025$11.14$11.02-1.08%$11.06$11.0150,468 shs$20.16 billion10/02/2025$11.02$11.14+1.09%$11.14$11.0896,096 shs$0.0010/01/2025$10.88$11.02+1.29%$11.37$10.87128,367 shs$0.0009/30/2025$10.80$10.88+0.74%$11.24$10.73378,035 shs$19.69 billion09/29/2025$11.05$10.80-2.26%$11.00$10.46611,564 shs$0.00 Get the Latest News and Ratings for ALPMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Astellas Pharma and its competitors with MarketBeat's FREE daily newsletter. 09/26/2025$11.07$11.05-0.16%$11.05$10.91126,209 shs$0.0009/25/2025$11.19$11.07-1.09%$11.30$11.0265,991 shs$0.0009/24/2025$11.28$11.19-0.80%$11.33$11.1756,173 shs$20.25 billion09/23/2025$11.33$11.28-0.44%$11.52$11.18115,299 shs$0.0009/22/2025$11.24$11.33+0.80%$11.49$10.8880,194 shs$0.0009/19/2025$11.56$11.24-2.77%$11.55$10.78109,153 shs$0.0009/18/2025$11.23$11.56+2.94%$11.64$11.24208,426 shs$20.92 billion09/17/2025$11.42$11.23-1.66%$11.30$11.1055,112 shs$0.0009/16/2025$11.41$11.42+0.09%$11.45$11.4153,328 shs$0.0009/15/2025$11.45$11.41-0.35%$11.75$11.29134,405 shs$20.65 billion09/12/2025$11.49$11.45-0.35%$11.45$11.0089,725 shs$20.72 billion09/11/2025$11.37$11.49+1.06%$11.87$11.4243,089 shs$0.0009/10/2025$11.47$11.37-0.87%$11.81$11.3244,025 shs$0.0009/09/2025$11.71$11.47-2.05%$11.75$11.4787,614 shs$20.76 billion Related Companies ACUS Stock Chart AOLS Stock Chart AOBI Stock Chart AXMP Stock Chart BIOAF Stock Chart BSPM Stock Chart CDXI Stock Chart COTQF Stock Chart HESG Stock Chart IAGX Stock Chart Receive ALPMY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Astellas Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:ALPMY) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenIf you're a futures trader (or want to be one), this could be the biggest shift you'll ever see in the prop fi...Neuro Street Trading Academy | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | SponsoredThe best AI stock you aren’t watching (but Elon is)Elon Musk's AI empire is already being built... not in the spotlight, but in the background. One public cou...Behind the Markets | SponsoredThe 7 Warning Signals Flashing Red Right NowA free report revealing the 7 key indicators that have predicted every major economic collapse since 1929. ...American Alternative | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astellas Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astellas Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
